Last reviewed · How we verify

NCT05586620

3 Snip Punctoplasty With and Without Mitomycine C.

Completed NA Last updated 19 October 2022
What this trial tests

NA trial testing 3-snip punctoplasty in Punctal Stenosis in 18 participants. Completed in 10 June 2022.

Timeline
1 June 2021
Primary endpoint
1 June 2022
10 June 2022

Quick facts

Lead sponsorAl-Azhar University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationnon randomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment18
Start date1 June 2021
Primary completion1 June 2022
Estimated completion10 June 2022
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Al-Azhar University

Who can join

Adults 16 to 63, any sex, with Punctal Stenosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Punctal stenosis is a progressive constriction of the puncta with resultant epiphora. One of the most effective treatment options is 1- to 4-snip punctoplasty combined with or without Mitomycin-C.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Punctal Stenosis

Currently open trials in the same condition.

Other Al-Azhar University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05586620.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing